SYNPLOGEN
Live / Registered — Registered (as of 04 Aug 2020)
What this means for you
Registered since 04 Aug 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79272215
- Registration number
- 6115549
- Mark type
- Stylized text
- Filed
- 22 Aug 2019
- Published for opposition
- 19 May 2020
- Registered
- 04 Aug 2020
- Attorney of record
- Rebeccah Gan
Goods and services
- Class 042 — Scientific and technological services: Research and development relating to DNA synthesis technology; technical advisory services and * providing * information technology consulting services relating to DNA synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems; scientific research in the fields of genetics and genetic engineering; DNA screening for scientific research purposes; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells; structural and functional analysis of the genome with genome synthesis technology; DNA screening for scientific research purposes with genome synthesis technology; research and development relating to genome synthesis technology; * providing * technical advisory services and information technology consulting services relating to genome synthesis technology; research and development, quality control for others, and technical advisory services relating thereto in the fields of protein, antibody, microorganisms, and cells, all with genome synthesis technology; research and development in the fields of bacteriology, cytology, antibody technology, chemistry, immunology, and gene expression systems, all with genome synthesis technology; scientific research in the fields of genetics and genetic engineering with genome synthesis technology; testing, inspection and research of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; * providing * technical advisory services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; information technology services relating to development of pharmaceuticals, cosmetics or foodstuffs, all with genome synthesis technology; testing, inspection and research relating to medical treatment or medical technology with genome synthesis technology; * providing * information technology consulting services for testing, inspection or research relating to medical treatment or medical technology with genome synthesis technology; testing and research relating to genome or gene to which genome synthesis technology is applied; research and development for the pharmaceutical industry and biotechnology industry with genome synthesis technology; research and development relating to biotechnology for others; research and development relating to genome synthesis technology for others; biotechnology research; research and development in the fields of genomics and biotechnology; technical advisory services in the fields of genomics and biotechnology; structural and functional analysis of genomes; testing, inspection or research on agriculture, livestock breeding or fisheries; development of pharmaceutical preparations and medicines; product development for others; research and development of new products for others; development of new technology for others in the fields of genomics and biotechnology; research and development of genome synthesis technology for others; research and development of new products for others with DNA synthesis technology; DNA synthesis services for others for scientific research purposes; research and development services in the field of gene expression systems; research and development services in the fields of microorganisms and cells; [ DNA sequence design services for scientific research purposes; ] research and development of microorganisms for others; research and development of microorganisms which produce useful substances for others; technical research in the field of microorganisms; bacteriological research; biological research
Owner
- Synplogen Co., Ltd., Hyogo, JP
- Synplogen Co., Ltd., Hyogo, JP
- Synplogen Co., Ltd., Hyogo, JP
Prosecution history
- 04 Aug 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 17 Feb 2023 — INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
- 24 Dec 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 30 Jul 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 25 Apr 2022 — LIMITATION FROM THE IB EXAMINED AND ENTERED
- 24 Apr 2022 — CORRECTION UNDER SECTION 7 - PROCESSED
- 05 Feb 2022 — LIMITATION OF GOODS RECEIVED FROM IB
- 12 Dec 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Nov 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Nov 2020 — FINAL DISPOSITION PROCESSED
- 04 Nov 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 04 Aug 2020 — REGISTERED-PRINCIPAL REGISTER
- 19 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 May 2020 — PUBLISHED FOR OPPOSITION
- 29 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED